发布时间：2025-10-23 13:56 Ad hoc announcement pursuant to Art. 53 LR



ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commercial and innovation momentum across its portfolio.


Record net sales of 3.737 billion USD for the first nine months of the year, representing net sales growth of 15.0% at constant currency1, despite challenging market dynamics, driven primarily by volume growth complemented by favorable mix

Widespread growth with acceleration across all geographies and product categories,including Injectable Aesthetics (+10.5%) with some phasing benefits in Neuromodulators, Dermatological Skincare (+8.2%), and Therapeutic Dermatology (+40.4%), all year-on-year for the first nine months of 2025 at constant currency

Advancing future growth drivers
=*=*=*=*=*=
当前为第1/31页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页